Accumulating evidence suggests that activation of the immune system in the central nervous system (CNS) after trauma protects the CNS from damage propagation and facilitates regeneration. Studies by our group have shown that passive transfer of autoimmune T cells specific to myelin basic protein (T MBP ) can protect injured neurons in the rat CNS from secondary degeneration. In this study, we investigated the effects of T MBP treatment on the local immune response (by B cells and macrophages) and on the expression of neurotrophic factors after crush injury of the rat optic nerve. Systemic injection of activated T MBP caused an increase in the accumulation of macrophages/microglia and B cells in the injured nerve, which was greater than that seen in the injured optic nerves of untreated animals. This accumulation was accompanied by a transient, but massive, increase in the expression of neurotrophic factors. Immunocytochemical analysis demonstrated differential expression of neurotrophins by resident astrocytes and by infiltrating B cells, T cells, and macrophages. Because postinjury neuronal survival and maintenance are known to be affected by neurotrophins, our findings point to a possible contribution of a neurotrophin-related mechanism to the protective effect conferred by T cell-mediated autoimmunity on injured neurons.
T raumatic injury to the central nervous system (CNS) results in immediate death of severed neurons as well as delayed death (by a process known as secondary degeneration) of neighboring cells that escaped the initial injury. A growing body of evidence suggests that activation of immune cells in response to CNS trauma can provide neurons with significant protection from these destructive events. Thus, systemic injection of T cells specific to CNS myelin-associated self-proteins such as myelin basic protein (MBP) results in an increase in the number of T cells accumulating at the site of the lesion. These T cells exert a neuroprotective effect by reducing the spread of damage to neurons that escaped the initial insult. This beneficial effect was demonstrated in two rat CNS models: the crush-injured optic nerve (1, 2) and the contused spinal cord (3) . Additional studies in our laboratory showed that in rats or mice of strains that are genetically resistant to the development of autoimmune disease, the number of surviving retinal ganglion cells (RGCs) after crush injury of the optic nerve is significantly smaller in animals devoid of mature T cells than in their normal counterparts (4, 5) . Studies in a different laboratory showed that the recovery of motor neurons after facial nerve transection in SCID mice, which lack functional T and B cells, is worse than in normal mice (6, 7) . In addition, implantation of activated macrophages into the completely transected optic nerves or spinal cords of rats was shown to facilitate axonal regeneration (8, 9) . These observations suggest that changing the environment of CNS axons by activation of immune cells may trigger an intrinsic capacity of the neurons to cope with injurious conditions. Owing to the immune-privileged character of the CNS, however, immune responses in the CNS are normally restricted. As a result, the potentially beneficial posttraumatic effects of the immune system are manifested only to a small extent, even in strains that are endowed with a beneficial immune mechanism.
The mechanisms underlying the neuroprotective effect of autoimmune anti-MBP T cells (T MBP ) in the injured CNS are not yet fully understood. Induction and activation of T lymphocytes require at least two signals from specific antigen-presenting cells (APCs). One signal results from binding of the T cell receptor to its antigen in the context of major histocompatibility complex (MHC). A second signal is provided by costimulatory molecules expressed by the APCs (10) . Two types of APCs that activate T cells are macrophages and B lymphocytes.
The effect of T MBP cells on the injured CNS might be exerted via a local dialogue with APCs that are recruited (as in the case of B cells and macrophages) or locally activated (as in the case of resident microglia) in the injured optic nerve. An alternative possibility is one in which neurotrophins (NTs) act as regulatory factors that mediate the neuroprotective effects of the T MBP . The NTs could be produced by the T MBP themselves, by other T cells, or by other immune or nonimmune cells recruited or activated by the T cells. Members of the NT family include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), and neurotrophin-6 (NT-6). In both the CNS and the peripheral nervous system, the NTs exert trophic activities on distinct or overlapping neuronal populations. These trophic effects include the development, maintenance, and survival of neurons (11) . Furthermore, studies have shown that treatment with NTs such as BDNF or NT-3 induces a neuroprotective effect on the injured CNS, expressed by survival of neurons and reduction in neuronal atrophy (12) (13) (14) . The biological activity of the NTs is mediated by interactions with two classes of cell-surface receptors: the low-affinity p75 receptor and members of the Trk family of tyrosine kinase receptors (TrkA, TrkB, and TrkC).
In addition to their effects on the nervous system, NTs are also active players in the immune system. NT gene expression and synthesis occur in lymphoid organs such as the spleen, thymus, and lymph nodes as well as in various immune cells, including lymphocytes, macrophages, and mast cells (15) (16) (17) (18) . NTs have also been shown to modulate a wide range of immune responses, for example, lymphocyte proliferation and differentiation (18, 19) , immunoglobulin synthesis (20, 21) , and macrophage activation (22, 23) . Furthermore, neurotransmitters such as norepinephrine or substance P can regulate lymphocyte expression of NTs (15) . The multifunctional participation of the NTs in both the nervous system and the immune system implies that these compounds are important mediators of the bidirectional cross-talk between the two systems.
Much research is currently directed toward identifying the mechanisms participating in immune cell-induced self-repair and finding ways to enhance them. In this study, using crush injury of the rat optic nerve as a model, we examined the effects of autoimmune T-cell treatment on the local expression of neurotrophic factors. We also examined the cellular source of these neurotrophic factors in the injured nerve.
MATERIALS AND METHODS

Animals
Inbred female Lewis rats (8−12 wk old) were supplied by the Animal Breeding Center of the Weizmann Institute of Science. The rats were housed in a light-and temperature-controlled room and matched for age in each experiment.
T cells
A T-cell line specific to MBP was generated from draining lymph node cells, obtained from Lewis rats immunized with MBP antigen (Sigma, St. Louis, MO), as previously described (2) . MBP was dissolved in phosphate-buffered saline (PBS) (1 mg/ml) and emulsified in an equal volume of incomplete Freund's adjuvant (IFA) (Difco Laboratories, Detroit, MI) supplemented with 4 mg/ml of Mycobacterium tuberculosis (Difco). The antigen was injected into the rats' hind foot pads in 0.1 ml of the emulsion. Ten days later, the rats were killed and their draining lymph nodes were surgically removed and dissociated. The cells were washed and activated with the antigen (10 µg/ml) in a stimulation medium containing Dulbecco's modified Eagle's medium (DMEM) supplemented with L-glutamine (2 mM), 2-mercaptoethanol (5×10 -5 M), sodium pyruvate (1 mM), penicillin (100 IU/ml), streptomycin (100 µg/ml), nonessential amino acids (1 ml/100 ml), and autologous serum 1% (v/v). After incubation for 72 h at 37°C, 98% relative humidity and 10% CO 2 , the cells were transferred to a propagation medium containing DMEM, L-glutamine, 2-mercaptoethanol, sodium pyruvate, nonessential amino acids, and antibiotics in the concentrations previously mentioned, with the addition of 10% fetal calf serum (FCS) (v/v) and 10% T-cell growth factor derived from the supernatant of concanavalin A (Con A)-stimulated spleen cells. Cells were cultured in the propagation medium for 4−10 days before restimulation with the antigen (10 µg/ml) in the presence of irradiated (2000 rad) thymus cells (10 7 cells/ml) in stimulation medium. The T-cell lines were expanded by repeated stimulation and propagation (24) . The T-cell line was checked for purity by fluorescence-activated cell sorter analysis, which confirmed that it was free of any contaminating cellular elements. The phenotype was previously tested and was found to be reminiscent of TH0 (25) .
Crush injury of optic nerves
Rats were deeply anesthetized by i.p. injection of XYL-M 2% (xylazine, 10 mg/kg; Arendonk, Belgium) and Ketaset (ketamine, 50 mg/kg; Fort Dodge Laboratories, Fort Dodge, IA). The optic nerve was subjected to crush injury as previously described (26) . The rat optic nerve was exposed under a binocular operating microscope, and calibrated cross-action forceps were used to inflict a crush injury 1−2 mm from the eye. Rats were subjected to severe crush injury of the intraorbital portion of the optic nerve. The contralateral nerve was left undisturbed and served as a control.
Immunohistochemistry
Longitudinal cryosections (10 mm thick) of the injured and uninjured nerves were placed on gelatin-coated glass slides and frozen until preparation for fluorescence staining. The sections were fixed in ethanol for 10 min at room temperature, washed twice with double-distilled water, and incubated for 3 min in PBS containing 0.05% Tween-20 (Sigma). To increase permeability and reduce nonspecific staining, the sections were incubated with a blocking solution containing 10% FCS, 2% bovine serum albumin, 1% glycine, and 0.1% Triton X100 in PBS. They were then incubated for 1 h at room temperature with primary antibodies diluted in the blocking solution. The primary antibodies consisted of monoclonal antibodies ED-1 (diluted 1:250; Serotec, Oxford, UK) for the labeling of activated macrophages and microglia; mouse anti-rat Tcell receptor (TCR, diluted 1:40 [27] ) for detection of T cells; mouse anti-rat glial fibrillary acid protein (GFAP, diluted 1:100; NeoMarkers, Fremont, CA) for identification of astrocytes; mouse anti-rat CD45R (diluted 1:40; Serotec, Oxford, UK) for identification of B cells; and rabbit polyclonal antibodies specific to amino acids 1−20 of rat NGF, amino acids 128−147 of rat BDNF, or amino acids 139−158 of rat NT-3 (Santa Cruz, CA).
The sections were then washed three times with PBS containing 0.05% Tween-20 and were incubated with fluorescein-conjugated secondary antibody, Alexa-488, Alexa-546 diluted 1:200 (Molecular Probes, Eugene, OR) or Cy3-conjugated goat anti-mouse IgG diluted 1:200 (Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. Negative control sections (not treated with primary antibody) were used to distinguish specific staining from nonspecific antibody binding and/or autofluorescent components of injured areas. The sections were then washed four times with PBS containing 0.05% Tween-20 and treated with mounting solution containing 1,4-diazobicyclo-(2,2,2)octane in glycerol to inhibit fluorescence quenching. The sections were viewed with a Zeiss laser-scanning confocal microscope (LSM510).
Immunohistochemical staining for localization of neurotrophins
To localize the cellular distribution of NGF, BDNF, and NT-3, we used an immunohistological method developed by Zhou and colleagues (28) . Rats were deeply anesthetized and perfused with 50 ml of 5% acetic acid buffer containing 0.9% NaCl (pH 3). They were then perfused with 200 ml of Zamboni's fixative containing 4% formaldehyde, 15% saturated picric acid, and 0.1 M phosphate buffer (pH 7.4). Optic nerves were dissected, postfixed in Zamboni's solution for 2 h, and soaked in 30% sucrose solution overnight. The nerves were washed three times in 50% alcohol and once in PBS and were cryosectioned (10 µm thick). The sections were placed on gelatin-coated glass slides and frozen until preparation for fluorescence staining. The sections were then stained according to the protocol described previously, with the following modifications: Sections were incubated with anti-NGF, anti-BDNF, or anti-NT-3 overnight at 4°C. They were then washed and incubated for 1 h with primary mouse anti-rat antibody to T cells, to macrophages/microglia, or to B cells, as described previously. After additional washing, the sections were incubated for 1 h with FITC-conjugated goat anti-rabbit and Cy3-conjugated goat anti-mouse IgG as secondary antibodies.
Fluorescence intensity evaluation
Fluorescence intensity was measured using Image-PRO PLUS 4.1 software.
Statistical analysis
Data sets were compared using one-way ANOVA or Sign test.
RESULTS
B-cell accumulation in injured optic nerve is significantly increased following injection of anti-MBP T cells
Studies in our laboratory have demonstrated that the accumulation of endogenous T cells in the injured optic nerve of the rat is significantly increased by systemic injection of activated autoimmune T cells such as T MBP (29, 30) . In an attempt to determine whether such injection affects homing of other immune cells to the injured nerve, we examined the homing of B cells to the crush-injured optic nerve.
Autoimmune T cells specific to MBP (T MBP ) were activated by incubation with MBP for 3 days and then injected (1 × 10 7 cells) i.p. into rats immediately after unilateral optic-nerve injury. Control rats were injected i.p. with PBS. Four days or 7 days after injury, injured and uninjured optic nerves were excised, cryosectioned, and analyzed immunohistochemically for the presence of B cells. No B cells were detected in the uninjured optic nerves. Some B cells were detected in the vicinity of the lesion in PBS-injected control rats (Fig. 1) , but significantly more were found at and distal to the site of injury in rats injected with T MBP . The accumulation of B cells was transient and had decreased by 7 days after the injury (Fig. 1) .
Injection of T MBP cells causes increased accumulation of microglia/macrophages in the injured optic nerve
In an attempt to compare the numbers of microglia/macrophages in the injured optic nerves of rats treated with T MBP to those in PBS-treated rats, we excised optic nerves 2, 3, and 4 days after injury and analyzed them immunohistochemically, using an antibody specific to both microglia and macrophages. By day 3, more microglia and macrophages were detected at and distal to the injury site in T MBP -treated rats than in PBS-treated rats (Fig. 2) . We observed an even greater relative increase in the T MBP -treated rats by day 4.
Expression of NTs is transiently increased in the injured optic nerve after injection of anti-MBP T cells
To examine the possibility that T MBP injection affects the expression of NTs at the site of injury, we first studied NGF expression. Expression of NGF was found to be at a maximum 4 days after the injury and T MBP injection. NGF immunoreactivity was transiently increased after injury, reaching a peak on day 4 and decreasing after 7 days. The amount of NGF detected in the injured nerve at that time was significantly higher (Sign test, P = 0.03, one-sided) in the T MBP -injected rats than in the PBS-injected rats (Fig. 3a) . This experiment was repeated at least five times with similar results. Fluorescence intensity, measured by image analysis, was increased by 3-to 11-fold. Expression of NGF in the injured optic nerves was much higher than in the uninjured contralateral nerves but was lower in the uninjured optic nerves of PBS-treated rats than in those of T MBP -treated rats (Fig. 3b) .
In view of the results with NGF, the expression of other NTs was studied 4 and 7 days after injury. Similar patterns were obtained for the expression of BDNF and NT-3. Thus, the injured nerves of T MBP -injected rats showed a transient increase in these two NTs, reaching a peak on day 4 (Fig. 4) and decreasing after 7 days (data not shown). Fluorescence intensity, measured by image analysis, showed an increase of 2-to 4-fold in the expression of BDNF in injured nerves (Fig. 4a) , and of 3-to 20-fold in NT-3 expression, relative to the injured nerves of PBS-injected rats (Fig. 4b) . The experiments with these NTs were also repeated five times, with similar results. Statistical analysis by Sign test revealed that the increase due to T MBP treatment was significant (one-sided, P = 0.03). Treatment with T MBP did not induce an increase in the expression of BDNF or NT-3 in uninjured contralateral optic nerves (data not shown).
Cellular localization of NTs in injured optic nerve
To examine the cellular sources of NGF, BDNF, and NT-3, we analyzed sections taken 4 days after injury from two rats treated with T MBP and two rats treated with PBS. Sections were labeled with anti-NGF (Fig. 4) , anti-BDNF (Fig. 6) , or anti-NT-3 ( Fig. 7) and were analyzed for the presence of these NTs in different cell types, as described in Materials and Methods. The results of these analyses revealed that astrocytes do not express NGF (Fig. 5) or BDNF (Fig. 6 ), but do express NT-3 (Fig. 7) ; T cells do not express NGF (Fig. 5 ), but do express BDNF (Fig. 6 ) and NT-3 (Fig. 7) ; B cells express NGF (Fig. 5) , BDNF (Fig. 6) , and NT-3 (Fig. 7) ; and macrophages/microglia express NGF (Fig. 5 ) and NT-3 ( Fig. 7) , but not BDNF (Fig. 6 ). The differences observed between injured nerves of T MBP -treated and untreated rats were not in the type or origin of the NTs expressed. Therefore, the data presented in Figures 5, 6 , and 7, indicating the cellular identities of the NTs in the optic nerve, show only cells from injured optic nerves of T MBP -treated rats.
DISCUSSION
The results of this study demonstrate that administration of autoimmune T cell in rats with injured optic nerves induces a local immune response, which is manifested by an increase in the number of microglia/macrophages and B cells. Furthermore, this beneficial autoimmune response is accompanied by a massive, but transient, increase in the expression of NGF, BDNF, and NT-3, beyond that observed as a result of the injury itself.
Studies in our laboratory have provided convincing evidence that the T cell-mediated autoimmune response, which is spontaneously evoked after CNS trauma (29) (30) (31) , is a physiological response aimed at reducing the posttraumatic loss of neurons (5) . Furthermore, systemic injection of specific T cells directed against a CNS myelin-associated protein, such as MBP, proteolipid protein (PLP), or myelin oligodendrocyte glycoprotein (MOG, NOGO), but not against ovalbumin or P277 of hsp60 peptides, promotes neuroprotection by reducing secondary degeneration after crush injury of the optic nerve or contusion of the spinal cord (2, 3, 32, 33).
The mechanisms underlying the neuroprotective effect of autoimmune T cells in the injured CNS
are not yet fully understood. Local blockade (in the optic nerve) of the Trk family of neurotrophin receptors (i.e., inhibition of Trk receptor signaling) by K252a causes marked suppression of the neuroprotective effect of T MBP in the injured rat optic nerve (25) . This observation, which points to the involvement of NTs in T cell-mediated neuroprotection, offers no clues about their cellular source. Activated autoimmune T cells are known to participate in the experimental induction of neurological diseases such as experimental autoimmune encephalomyelitis (EAE) in animal models (and thus are also referred to as encephalitogenic T cells) (34) (35) (36) . It was therefore suggested that this autoimmune response to CNS injury might be capable of both a beneficial effect on neuronal survival and destruction of the myelin sheath (3, 37) . A recent study by our group showed that the beneficial autoimmune response is dependent on myelin-specific Th1 cells and on regulatory CD4+ T cells (38) . That observation led us to suggest that the autoimmune T cells, provided that their response is well regulated, enter into a dialogue with resident microglia or invading macrophages that helps clear the injured nerve of potentially destructive self-compounds. Future research should be directed to determining which immune signals induce a protective T-cell response and which produce a destructive response. Such knowledge will enable us to ensure that this therapeutic approach will induce the benefit without the risk of harmful side effects such as autoimmune disease.
The results of this study, demonstrating the presence of B cells in the injured optic nerve, are in line with reported findings of an increase in the amounts of antibodies specific to neuronal antigens after CNS injury in the rat, both at the injury site and systemically (39) (40) (41) . B cells were shown to efficiently restimulate only Th2 cells (42) . Recent studies in our laboratory showed that at least some of the T cells that accumulate at the site of injury 7 days after spinal cord contusion are of the Th2 type, because the mRNA they express is mostly of IL-10 and GATA-3 but not of IFN-γ (5). Because protective autoimmunity cannot operate in the absence of well-regulated autoimmune T cells of the Th1 phenotype (38, 43) , it is possible that the switch from Th1 to Th2 reflects this essential regulation (38, 43) . It is therefore possible that the B cells, which are recruited subsequent to the T cell injection, contribute to the timely regulation of the T-cell response by allowing a switch in phenotype from Th1 to Th2, which presumably occurs within the therapeutic window.
Studies have shown that in mice with EAE induced either by immunization with MBP or by passive transfer of myelin-reactive CD4+ T cells, the onset of EAE correlates with the induction of a Th1-type response (44) (45) (46) , whereas remission of the disease correlates with a Th2-type response (47, 48) . Activated microglia/macrophages represent other candidate cell types that may regulate the balance between Th1 and Th2 responses in the CNS. These cells were found to play an important role in the regulatory network by activating a Th1 response and restimulating Th2 cells (49) . Additional studies are currently underway to determine the physiological regulatory mechanisms required to boost the spontaneously evoked protective autoimmunity in strains known to be resistant to EAE and to induce it in susceptible strains, such as Lewis rats, that have a limited immune response. The substantial expression of NTs by B cells suggests a possible role of these immune cells in the survival of injured neurons. However, recent studies in our laboratory, conducted in a mouse strain susceptible to EAE (and thus also limited in its ability to manifest protective immunity), demonstrated that B cells may also have a destructive effect after CNS insult (50) . We therefore suggest that the beneficial effect of B cells might be dependent on proper T-cell regulation and might occur in conjunction with the accumulation of T cells in the injured CNS.
In view of our finding that the number of microglia/macrophages in the injured nerve is significantly increased after passive transfer of T MBP , it is reasonable to assume that these immune cells play an important role in mediating the effects of autoimmune T cells. Several studies have demonstrated that macrophages have the ability to induce neuronal regrowth and partial recovery after injury (9, (51) (52) (53) (54) . Among the mechanisms that appear to contribute to this beneficial macrophage effect are phagocytosis and clearance of myelin, secretion of cytokines and growth factors, free-radical production, and enzyme secretion (for review, see ref 55) . Note, however, that the effect of microglia/macrophages on neurons can also be harmful. It has been suggested that whether the effect of these phagocytic cells on neurons is beneficial or harmful depends on their number, state of activation, B-7 phenotype, and cellular context (56, 57) . The massive increase in the number of NT-expressing microglia/macrophages in the presence of T MBP raises the possibility that interaction between T cells and microglia/macrophages in the context of CNS injury has a beneficial effect on the damaged neuronal tissue.
Lewis rats, used in this study, are susceptible to EAE. T MBP induces EAE within several days of their inoculation into naïve recipient rats. Several studies provide evidence that NGF is significantly increased in the brains of rats affected by EAE. It has also been suggested that NGF contributes to the protection from neuronal damage during EAE (58, 59) . Our findings suggest that the cellular events in the uninjured contralateral nerves are similar in type to those occuring in EAE, because T cells reach the naïve optic nerve a few days after their injection and induce an increase in NGF there. In the injured nerve, however, greater amounts of NGF, as well as of BDNF and NT-3, are seen as a result of the infiltrating T cells. Differences between the injured and the uninjured nerve may thus be attributable to the increase in the number of T cells (as well as B cells and macrophages) that reach the nerve after a severe crush injury.
Our results clearly show that autoimmune T cells induce the appearance of large amounts of NGF, BDNF, and NT-3 in the injured optic nerve of the rat. In attempting to determine the cellular source of these NTs, we demonstrated that they are differentially expressed by resident astrocytes and by infiltrating B cells, T cells, and macrophages. Because the same NTs were expressed in the cells of PBS-treated and T MBP -treated rats, we assumed that the cells that are directly or indirectly responsible for the increase in NTs in the injured nerves of the T MBP -treated rats are mainly the infiltrating cells, that is, T cells, B cells, macrophages, or the residual activated microglia. Our results confirm and extend the evidence from previous studies on the expression of NTs in T and B lymphocytes (15, 23, 25) , macrophages (22, (60) (61) (62) , microglia (63, 64) , and astrocytes (65) . In addition, our results are consistent with those of Hammarberg et al. (66) , who reported large amounts of BDNF and NT-3 in T-cell and natural killer cell populations that infiltrated the CNS after immunization with an encephalitogenic MBP peptide in a model of ventral root avulsion in adult rats.
NTs reportedly play an important role in the generation, differentiation, survival, and regeneration of neurons after injury to neuronal tissues (12, 14, 67) . In addition, NTs have an immunomodulatory effect on immune responses and inflammation (18, 68) . For example, NGF was shown to enhance T cell-and B cell-mediated immune responses (19, 69) and to promote monocyte/macrophage phagocytic function, antimicrobial activity, IL-1 production (70), and secretion of tumor necrosis factor α and nitric oxide (22, 61) . NGF also enhances the survival and cytotoxic activity of eosinophils (71), increases the number of mast cells (72) , and promotes differentiation of granulocytes (73) .
In view of these findings, it is tempting to speculate that the beneficial effect of autoimmune T cells in protecting injured nerves may be mediated, at least in part, by NTs. The NTs may influence neuronal survival, both directly through binding to their receptors on the neurons and indirectly by modulating the local immune response. In agreement with this assumption, a recent study in our laboratory demonstrated expression of the NT receptors TrkA, TrkB, and p75 in the injured optic nerve.
According to our results, the major source of NTs are B cells and microglia/macrophages, whereas smaller quantities of NTs are expressed by T cells and astrocytes. Given that more B cells and macrophages accumulate in the injured nerve after injection of T MBP cells than after injection of PBS, we suggest that the arrival of T cells at the injured nerve is of key importance in regulating the accumulation of B cells and macrophages there. Under the influence of their regulatory mechanism, T cells may be induced to exhibit a vital phenotype, and the cytokines secreted by this T-cell phenotype may then mediate the neuroprotective effect of T MBP .
The pattern of transient expression of NTs in T MBP -treated nerves (namely, high expression that peaks 4 days after T MBP administration and decreases after 7 days) correlates with the transient accumulation of T cells (30) and B cells and with the increase in the number of macrophages in the injured optic nerve .The pattern is also consistent with other findings by our group suggesting that the therapeutic window of opportunity with T MBP , in both optic nerve and spinal cord injuries, lasts for 7 days after the injury (2, 3).
Note that our results were obtained in Lewis rats, which are known to be susceptible to EAE. Recent studies by our group have provided evidence that protective autoimmunity in the injured CNS is genetically controlled and is inversely related to susceptibility to the development of an autoimmune disease (43) . Thus, the patterns of immune response and NT secretion in resistant strains might be different from those demonstrated here.
In conclusion, we show that an autoimmune T-cell response to CNS injury leads to a robust local innate response and a massive increase in the amounts of NTs expressed by T cells, B cells, microglia/macrophages, and astrocytes in the injured optic nerves of Lewis rats. This finding may shed light on the protective signaling pathways that operate following the autoimmune Tcell response to injury. 1 . B cell infiltration 4 days and 7 days after optic nerve injury. Adult Lewis rats were injected with activated T MBP or with phosphate-buffered saline (PBS) immediately after unilateral crush injury of the optic nerve. After 4 or 7 days, both the injured and the uninjured optic nerves were removed, cryosectioned, and analyzed immunohistochemically for the presence of immunolabeled B cells. A) Immunolabeled B cells in a representative cryosection taken from the injured nerve of a rat injected with T MBP or PBS 4 days or 7 days after injury. B) Histograms show the mean numbers of B cells per cryosection (10 mm thick and 6 mm long) ±SE, counted in groups containing three to four rats. Statistical analysis (one-way ANOVA) showed that the number of B cells in the injured optic nerve of rats injected with T MBP was significantly higher than that of rats injected with PBS 4 days and 7 days after injury (P < 0.001). Also, the number of B cells 4 days after injury in the injured optic nerves was significantly higher than that in the uninjured optic nerves of rats injected with T MBP 4 days or 7 days after injury (P < 0.001) or with PBS 4 days after injury (P <0.05). rats were injected with activated T MBP or with PBS immediately after unilateral crush injury of the optic nerve. After 2, 3, or 4 days, the injured optic nerves were removed, cryosectioned, and analyzed immunohistochemically for the presence of immunolabeled microglia/macrophages. A) Immunolabeled microglia/macrophages in a representative cryosection taken from the injured nerve of a rat injected with T MBP or PBS 4 days after injury. B) Histograms show the mean numbers (±SE) of microglia/macrophages per cryosection (10 mm thick and 6 mm long) 2, 3, or 4 days after injury, counted in groups containing two to four rats. Statistical analysis (one-way ANOVA) showed that the number of microglia/macrophages in the injured optic nerve of rats injected with T MBP was significantly higher than that of rats injected with PBS 4 days after injury (P < 0.05). 
